Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP169 | DOI: 10.1530/endoabs.90.EP169

1La Rabta University Hospital, Department of Endocrinology, Tunis, Tunisia; 2La Rabta University Hospital, Department of Internal Medicine, Tunis, Tunisia


Introduction: Primary hyperparathyroidism is a common endocrine disease. Its association with inflammatory and thrombotic events was rarely reported in the literature. The pathophysiological mechanisms of this association remain uncertain. Herein, we report a case of hypercalcemia secondary to primary hyperparathyroidism revealed by a deep vein thrombosis.

Observation: A 65-year-old patient was referred to our department for primary hyperparathyroidism. The patient was admitted to the department of internal medicine for a deep vein thrombosis in the left lower limb. On physical examination, he had a body weight of 68 kg, a height of 165 cm, a body mass index of 24.9 kg/m2, a blood pressure of 12/08 cmHg, and a heart rate of 57 beats/min. Other systemic and regional examinations did not show any abnormalities. Potential causes of vein thrombosis were excluded. Biological investigations showed a total calcium level of 3.3 mmol/l, a phosphorus level of 0.49 mmol/l, a creatinine level of 60.9 mmol/l, a PTH level of 163 ng/l, albumin level of 43 g/l, a 25 hydroxyvitamin D of 20.2 ng/ml, and a calciuria of 0.21 mmol/24 h. The diagnosis of primary hyperparathyroidism was established. Cervical ultrasound and Sestamibi scan showed a left inferior parathyroid nodule measuring 12.5 × 7 mm. Bone mineral density scan revealed osteoporosis. No other complications were observed. The patient was treated with saline intravenous hydration, zoledronic acid, and a therapeutic dose of low-molecular-weight-heparin. Then, he underwent a left inferior parathyroidectomy. The postoperative course was simple with a total calcium level of 2.25 mmol/l.

Discussion: Thrombotic events were reported in a few patients with primary hyperparathyroidism. This association may be explained by direct activation of prothrombotic factors and hemoconcentration. Even though hypercalcemia is a rare cause of thrombotic events, it should be considered in the clinical evaluation of patients with deep vein thrombosis in the absence of evident causes.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts